HomeTagsNeoadjuvant chemotherapy

neoadjuvant chemotherapy

Healthcare

IMFINZI-based treatment before and after surgery reduced the risk of disease recurrence, progression events or death by 32% in resectable non-small cell lung cancer...

Business Wire - April 17, 2023

Positive results from the AEGEAN Phase III trial showed that treatment with AstraZeneca’s IMFINZI in combination with neoadjuvant chemotherapy before surgery and as adjuvant monotherapy...

Hot Topics

Peraton and Okta Collaborate with U.S. DoD to Advance myAuth

Vontier’s Driivz Team Up With ENAPI for EV Roaming Connectivity

Zuora and Workday Partners for Revenue Management and Financial Accuracy